This adds to the 3,000 doses of a similar medicine, RegN-Cov 2, developed by Switzerland’s Roche and US biotech company Regeneron.
Monoclonal antibodies, which are cloned in culture and injected into patients, are seen as highly promising treatments to neutralise the virus, particularly in serious cases of infection. The antibody was discovered by Swiss company Humabs BioMed.
Although the sotrovimab drug has yet to be granted regulatory approval in Switzerland, trials by GlaxoSmithKline show promising results, the government said in a press release on FridayExternal link.
The reservation of 3,000 doses of the drug was made on the recommendation of the Swiss National Covid-19 Taskforce.
The drug is intended as a treatment for at-risk patients who have an increased risk of severe infection.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Porrentruy mayor comments on Swiss pool ban controversy
This content was published on
The mayor of the Swiss town of Porrentruy, which has been in the headlines in neighbouring France after restricting access to a pool to locals after a spate of anti-social behaviour, says he has received much support in recent days.
Swiss universities to release multilingual AI programme
This content was published on
This summer researchers at Swiss universities will make available a large language model (LLM), an AI programme trained on vast amounts of data, developed on public infrastructure.
This content was published on
After a one-year test phase, Zurich's cantonal police are introducing an online police station. Demand is high and the response from the public has been positive.
This content was published on
The chic resort of St Moritz in southeastern Switzerland has registered "summer" as a trademark under the name "St Summer". The resort in canton Graubünden is launching a campaign to strengthen its summer business.
Swiss authorities detail progress on station access for people with reduced mobility
This content was published on
The Federal Office of Transport (FOT) said on Wednesday that 43 stations had been adapted for people with reduced mobility last year. The vast majority of rail travellers (82%) now benefit from easier access to stations, it says.
This content was published on
The prices of homes and apartments in Switzerland rose again in June. In the Lake Geneva region, prices of detached houses rose sharply. Meanwhile, in Zurich and its surrounding region the opposite trend was observed.
Crowded airports expected in Switzerland this summer
This content was published on
Switzerland's main airports are preparing for a busy summer holiday period. A number of changes have been introduced to improve passenger flows that are expected to be well above average in July and August.
Zurich police arrest 38 football and hockey fans after violent incidents
This content was published on
Zurich police have investigated 48 cases of fan violence at stadiums in the Swiss city since last autumn and arrested a total of 38 people, Swiss public television, SRF, reports.
Cashflow problems affect UN Human Rights Council activities
This content was published on
Certain activities of the Geneva-based United Nations Human Rights Council cannot be carried out in 2025-2026 due of the ongoing cash crisis affecting the UN.
Plaintiffs take Khaled Nezzar case to European Court of Human Rights
This content was published on
Two plaintiffs in a serious war crimes case against former Algerian Defence Minister Khaled Nezzar have filed an appeal with the European Court of Human Rights.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Chair of pharma firm Roche advocates mandatory Covid-19 vaccination
This content was published on
Christoph Franz said he was in favour of compulsory jabs if vaccination coverage rates were insufficient and if there was a social consensus.
This content was published on
Although it has only been in operation since 2000, the Institute of Research in Biomedicine (IRB) has already become a centre of international importance in the field of biomedical research. It has over 300 publications to its credit in academic journals, including Science and Nature. A visitor arriving at the institute for the first…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.